drugset / Trial / NCT00833794

A Two-Arm Study Comparing the Analgesic Efficacy and Safety of Tramadol HCl Once-a-Day Versus Placebo for the Treatment of Pain Due to Osteoarthritis

NCT00833794

Phase 3 Completed 1028 enrolled Labopharm Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the analgesic efficacy, safety and clinical benefit of Tramadol OAD tablets versus Placebo.

Timeline

Start
2004-10
Primary completion
2006-01
Completion
2006-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Tramadol Other / unclassified 200 mg
Subject Tramadol Other / unclassified 300 mg

Indications